{"id":"https://openalex.org/W1963645877","doi":"https://doi.org/10.1016/s0278-5846(96)00134-0","title":"A schematic representation of the psychopharmacological profile of antidepressants","display_name":"A schematic representation of the psychopharmacological profile of antidepressants","publication_year":1996,"publication_date":"1996-11-01","ids":{"openalex":"https://openalex.org/W1963645877","doi":"https://doi.org/10.1016/s0278-5846(96)00134-0","mag":"1963645877","pmid":"https://pubmed.ncbi.nlm.nih.gov/9004345"},"language":"en","primary_location":{"id":"doi:10.1016/s0278-5846(96)00134-0","doi":"https://doi.org/10.1016/s0278-5846(96)00134-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0278-5846(96)00134-0","pdf_url":null,"source":{"id":"https://openalex.org/S142279999","display_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","issn_l":"0278-5846","issn":["0278-5846","1878-4216"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1963645877"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074125552","display_name":"Michel Bourin","orcid":"https://orcid.org/0000-0002-7268-4590","observed_orcids":["https://orcid.org/0000-0002-7268-4590"]},"institutions":[{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Michel Bourin","raw_affiliation_strings":["GIS Medicament, Department of Pharmacology, Faculty of Medicine, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GIS Medicament, Department of Pharmacology, Faculty of Medicine, Nantes, France","institution_ids":["https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109915456","display_name":"John Paul Redrobe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"John Paul Redrobe","raw_affiliation_strings":["GIS Medicament, Department of Pharmacology, Faculty of Medicine, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GIS Medicament, Department of Pharmacology, Faculty of Medicine, Nantes, France","institution_ids":["https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038679486","display_name":"Martine Hasco\u00ebt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Martine Hascoet","raw_affiliation_strings":["GIS Medicament, Department of Pharmacology, Faculty of Medicine, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GIS Medicament, Department of Pharmacology, Faculty of Medicine, Nantes, France","institution_ids":["https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088403251","display_name":"Glen B. Baker","orcid":"https://orcid.org/0000-0003-1581-6486","observed_orcids":["https://orcid.org/0000-0003-1581-6486"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Glen B. Baker","raw_affiliation_strings":["Neurochemical Research Unit, Department of Psychiatry, University of Alberta, Edmonton, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurochemical Research Unit, Department of Psychiatry, University of Alberta, Edmonton, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"last","author":{"id":null,"display_name":"Marie-Claude Colombel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-Claude Colombel","raw_affiliation_strings":["GIS Medicament, Department of Pharmacology, Faculty of Medicine, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GIS Medicament, Department of Pharmacology, Faculty of Medicine, Nantes, France","institution_ids":["https://openalex.org/I97188460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5074125552"],"corresponding_institution_ids":["https://openalex.org/I97188460"],"apc_list":{"value":4380,"currency":"USD","value_usd":4380},"apc_paid":null,"fwci":0.8113,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.71181664,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"20","issue":"8","first_page":"1389","last_page":"1402"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9419000148773193,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9419000148773193,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.051100000739097595,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9649999737739563},{"id":"https://openalex.org/keywords/dothiepin","display_name":"dothiepin","score":0.9179999828338623},{"id":"https://openalex.org/keywords/mianserin","display_name":"mianserin","score":0.9570000171661377},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.996999979019165},{"id":"https://openalex.org/keywords/maprotiline","display_name":"maprotiline","score":0.9660000205039978},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":1.0},{"id":"https://openalex.org/keywords/viloxazine","display_name":"viloxazine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/forced-swim-test","display_name":"forced swim test","score":0.765999972820282},{"id":"https://openalex.org/keywords/immobility-time","display_name":"immobility time","score":0.824999988079071},{"id":"https://openalex.org/keywords/disinhibition","display_name":"disinhibition","score":0.9620000123977661},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.984000027179718},{"id":"https://openalex.org/keywords/antidepressant-screening","display_name":"antidepressant screening","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C192328126","wikidata":"https://www.wikidata.org/wiki/Q4514647","display_name":"Schematic","level":2,"score":0.9386217594146729},{"id":"https://openalex.org/C2776359362","wikidata":"https://www.wikidata.org/wiki/Q2145286","display_name":"Representation (politics)","level":3,"score":0.6864117383956909},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.503832995891571},{"id":"https://openalex.org/C180747234","wikidata":"https://www.wikidata.org/wiki/Q23373","display_name":"Cognitive psychology","level":1,"score":0.336908221244812},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.07277575135231018},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.06778424978256226},{"id":"https://openalex.org/C94625758","wikidata":"https://www.wikidata.org/wiki/Q7163","display_name":"Politics","level":2,"score":0.0},{"id":"https://openalex.org/C24326235","wikidata":"https://www.wikidata.org/wiki/Q126095","display_name":"Electronic engineering","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001923","descriptor_name":"Brain Chemistry","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015016","descriptor_name":"Yohimbine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015016","descriptor_name":"Yohimbine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0278-5846(96)00134-0","doi":"https://doi.org/10.1016/s0278-5846(96)00134-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0278-5846(96)00134-0","pdf_url":null,"source":{"id":"https://openalex.org/S142279999","display_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","issn_l":"0278-5846","issn":["0278-5846","1878-4216"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","raw_type":"journal-article"},{"id":"pmid:9004345","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9004345","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in neuro-psychopharmacology & biological psychiatry","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1486881060","https://openalex.org/W1521146723","https://openalex.org/W1838505387","https://openalex.org/W1964144827","https://openalex.org/W1965027767","https://openalex.org/W1965576369","https://openalex.org/W1968648566","https://openalex.org/W1971097055","https://openalex.org/W1972759971","https://openalex.org/W1979420282","https://openalex.org/W1981929657","https://openalex.org/W1992176680","https://openalex.org/W2010111580","https://openalex.org/W2013082402","https://openalex.org/W2014618530","https://openalex.org/W2017452849","https://openalex.org/W2021289073","https://openalex.org/W2027120048","https://openalex.org/W2030279660","https://openalex.org/W2037177382","https://openalex.org/W2042997554","https://openalex.org/W2049372289","https://openalex.org/W2052468847","https://openalex.org/W2052521265","https://openalex.org/W2062143151","https://openalex.org/W2080402976","https://openalex.org/W2084574604","https://openalex.org/W2089299823","https://openalex.org/W2090892375","https://openalex.org/W2093070202","https://openalex.org/W2102456354","https://openalex.org/W2170029774","https://openalex.org/W2192167800","https://openalex.org/W2395231159","https://openalex.org/W4206680248","https://openalex.org/W4245414404","https://openalex.org/W6661284143","https://openalex.org/W6792839414"],"related_works":["https://openalex.org/W2804399043","https://openalex.org/W2006917968","https://openalex.org/W2088930544","https://openalex.org/W2056009025","https://openalex.org/W2052376597","https://openalex.org/W2142146475","https://openalex.org/W2005594217","https://openalex.org/W1968474522","https://openalex.org/W2197078876","https://openalex.org/W3147261446"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}